Abeona Therapeutics (ABEO) Assets Average (2011 - 2026)

Abeona Therapeutics' Assets Average history runs 16 years deep, the most recent figure standing at $209.0 million for Q1 2026.

• In Q1 2026, Assets Average rose 100.71% year-over-year to $209.0 million; the TTM figure through Mar 2026 stood at $209.0 million (up 100.71% YoY), while the FY2025 annual figure was $164.3 million, up 89.96% from the prior year.
• Assets Average for Q1 2026 stood at $209.0 million, down from $225.3 million in the prior quarter.
• The five-year high for Assets Average was $238.7 million in Q3 2025, with the low at $41.7 million in Q3 2022.
• The 5-year median for Assets Average is $69.4 million (2024), against an average of $106.7 million.
• The sharpest annual moves came in 2022 and 2024: Assets Average slumped 66.57% in 2022, then surged 112.81% in 2024.
• Abeona Therapeutics' Assets Average stood at $51.5 million in 2022, then increased by 26.33% to $65.0 million in 2023, then surged by 76.44% to $114.8 million in 2024, then surged by 96.35% to $225.3 million in 2025, then dropped by 7.23% to $209.0 million in 2026.
• Business Quant data shows ABEO's Assets Average at $209.0 million in Q1 2026, $225.3 million in Q4 2025, and $238.7 million in Q3 2025.